share_log

Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5

Benzinga ·  Jun 18 17:42

Lake Street analyst Frank Takkinen downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and lowers the price target from $28 to $27.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment